captvivekjain
Long

Divi's Labs is a sure-shot pill to profit

NSE:DIVISLAB   DIVI'S LABORATORIE
159 2 6
The scrip is at Rs             774 with a price and volume break-out today.
It is resting on 20D EMA and with NIFTY's assistance in coming weeks, may gallop to close the huge fall experienced earlier from Rs             1100 levels mainly due to US FDA inspection and recommendations.
The company has completed the recommendations satisfactorily and is waiting for market fancy.
Technically and fundamentally, it is underpriced. Book Value is a healthy Rs             195, PE=18, a debt-free balance sheet , growing turnover and profits, it should return to its previous glory             pretty soon.
Thanks for your views, I am adding it right away to my portfolio !
Reply
Thanks for your wonderful analysis!

Agree with your views - I have a lot of Divi's Lab shares in my portfolio - I also believe it is fundamentally very sound and shown consistent profit and growth in all segments over the years and presents a very good opportunity to buy currently.
+1 Reply
EN English (IN)
EN English
EN English (UK)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
HE עברית
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out